# BEYOND Pilot Study

> **NCT00893217** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 71 (actual)

## Conditions studied

- Multiple Sclerosis
- Relapsing-Remitting

## Interventions

- **DRUG:** Betaseron (Interferon beta-1b, BAY86-5046)
- **DRUG:** Betaseron (Interferon beta-1b, BAY86-5046)

## Key facts

- **NCT ID:** NCT00893217
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2009-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893217, "BEYOND Pilot Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00893217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*